Jazz Pharmaceuticals (JAZZ) shares outstanding

Shares outstanding · fiscal 2025
60.98M

Jazz Pharmaceuticals (JAZZ) had 60.98M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 7.6% lower than the 66.01M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
60.98M
Change on fiscal 2024
−7.6%
Growth, 5 years
+1.5% a year
Growth, 10 years
−0.3% a year
Highest on record
72.07Mfiscal 2023
Lowest on record
30.02Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Jazz Pharmaceuticals shares outstanding, in more detail

The market data feed counts 64.19M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.5% a year; over ten years the rate was −0.3% a year. Across the 17 fiscal years on record (2009–2025), the highest was 72.07M in fiscal 2023 and the lowest 30.02M in fiscal 2009.

History · 17 fiscal years

Shares outstanding by fiscal year

Jazz Pharmaceuticals shares outstanding, year by year

Jazz Pharmaceuticals (JAZZ) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202560.98M 7.6% down
202466.01M 8.4% down
202372.07M 15.2% up
202262.54M 4.8% up
202159.69M 5.6% up
202056.52M 1.8% down
201957.55M 6.0% down
201861.22M 0.2% down
201761.32M 0.9% down
201661.87M 1.8% down
201563.04M 0.7% up
201462.61M 1.7% up
201361.57M 2.3% up
201260.20M 28.6% up
201146.80M 18.7% up
201039.41M 31.3% up
200930.02M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Jazz Pharmaceuticals and comparable companies
CompanyShares outstandingFiscal year
Neurocrine Biosciences NBIX102.50M2025
Ascendis Pharma ASND60.61M2025
ICON ICLR79.09M2025
Jazz Pharmaceuticals JAZZ60.98M2025
Solventum SOLV175.30M2025
BridgeBio Pharma BBIO191.53M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals shares outstanding: questions and answers

How many shares does Jazz Pharmaceuticals have?

Jazz Pharmaceuticals (JAZZ) had 60.98M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 7.6% lower than the 66.01M of fiscal 2024. The market data feed counts 64.19M shares outstanding today.

What is the growth rate of Jazz Pharmaceuticals's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 1.5% a year; over ten years the rate was −0.3% a year.

What are the highest and lowest diluted share count figures on record for Jazz Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was 72.07M in fiscal 2023 and the lowest 30.02M in fiscal 2009.

How is Jazz Pharmaceuticals's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Jazz Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.